Andrew J. Fromkin, Director at Immunovant, Inc. (IMVT), bought 5,500 shares at $7.90 ($43K) on 2021-08-10, disclosed to the SEC on 2021-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMVT | SELL | 2025-03-11 | $286K | — | Filing → |
| IMVT | SELL | 2023-12-05 | $981K | — | Filing → |